Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gene therapy (2) 2
immunotherapy (2) 2
acute myeloid leukemia (1) 1
adoptive cell therapy (1) 1
antigens (1) 1
antitumor activity (1) 1
b-cell (1) 1
bone marrow (1) 1
cancer immunotherapy (1) 1
cancer therapies (1) 1
cd4 antigen (1) 1
cd8 antigen (1) 1
cell differentiation (1) 1
chemotherapy (1) 1
class-ii epitopes (1) 1
crispr/cas (1) 1
gene transfer (1) 1
genomes (1) 1
hematology (1) 1
hematopoietic stem cells (1) 1
hemic and lymphatic diseases (1) 1
histocompatibility antigen hla (1) 1
identification (1) 1
immune-responses (1) 1
immunodeficiency (1) 1
index medicus (1) 1
leukemia (1) 1
leukemias (1) 1
ligands (1) 1
lymphocytes (1) 1
lymphocytes t (1) 1
lysis (1) 1
medicine, research & experimental (1) 1
multiple myeloma (1) 1
multiple-myeloma (1) 1
mutation (1) 1
mutations (1) 1
myeloid leukemia (1) 1
patients (1) 1
peptide (1) 1
peptides (1) 1
proteins (1) 1
reading (1) 1
receptor (1) 1
research (1) 1
research article (1) 1
t cell (1) 1
t cell receptor (1) 1
t cell receptors (1) 1
t-cell receptor (1) 1
t-cells (1) 1
tcr (1) 1
transplantation (1) 1
tumor-antigens (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
by Van Der Lee, Dyantha I and Reijmers, Rogier M and Honders, Maria W and Hagedoorn, Renate S and De Jong, Rob C.M and Kester, Michel G.D and Van Der Steen, Dirk M and De Ru, Arnoud H and Kweekel, Christiaan and Bijen, Helena M and Jedema, Inge and Veelken, Hendrik and Van Veelen, Peter A and Heemskerk, Mirjam H.M and Frederik Falkenburg, J.H and Griffioen, Marieke
Journal of Clinical Investigation, ISSN 0021-9738, 02/2019, Volume 129, Issue 2, pp. 774 - 785
The most frequent subtype of acute myeloid leukemia (AML) is defined by mutations in the nucleophosmin 1 (NPM1) gene. Mutated NPM1 (Delta NPM1) is an... 
MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | B-CELL | TUMOR-ANTIGENS | CLASS-II EPITOPES | IMMUNE-RESPONSES | RECEPTOR | MUTATIONS | IDENTIFICATION | T-CELLS | PEPTIDE | Usage | Transplantation | Research | Cell differentiation | Immunotherapy | Hematopoietic stem cells | Peptides | CD8 antigen | Leukemia | Multiple myeloma | Lymphocytes T | Genomes | Cancer therapies | Proteins | T-cell receptor | Lymphocytes | Bone marrow | Antigens | Gene transfer | Myeloid leukemia | Immunodeficiency | T cell receptors | Patients | CD4 antigen | Reading | Chemotherapy | Lysis | Antitumor activity | Ligands | Histocompatibility antigen HLA | Mutation | Gene therapy | Acute myeloid leukemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic
by Morton, Laura T and Reijmers, Rogier M and Wouters, Anne K and Kweekel, Christiaan and Remst, Dennis F.G and Pothast, Cilia R and Falkenburg, J.H. Frederik and Heemskerk, Mirjam H.M
Molecular Therapy, ISSN 1525-0016, 10/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.